In recent, various human health disorders including cancer, diabetes, neurodegenerative and metabolic diseases are noticed among human populations. Currently, genetic and proteomic approaches are highly reported to detect metabolic disorders that also include inborn error of metabolisms. These existing detection methods are faced with cost issue and time consuming factors. Therefore, metabolites as biomarkers are one of potential avenues to detect metabolic disorders. Further, exploitation of urine as potential source of metabolite biomarkers, there are limitation in this area of research due to abundance of non-metabolite components such as proteins and nucleic acids. Hence, methods and processes are required to precisely fractionate metabolites from urine of inborn error of metabolism patients and then identified by analytical tools such as LC-HRMS and GC-MS.
INTRODUCTION
Among various classes of metabolic disorders, organic acidurias a type of inherited metabolic disorders is known to surface as intermediate steps in a metabolic pathways of anabolism and catabolism of lipid, carbohydrate, nucleic acids and amino acids (1) (2) (3) (4) (5) . In essence, these metabolic disorders are indicated to lead to abundance of organic acids including 2methyluridine, 2-Methylglutaric acid, 2-Methyl citric acid, 2-Hydroxyglutaric acid in a relevant tissues and these metabolites are potentially excreted in urine (5) (6) (7) (8) (9) (10) (11) (12) (13) .
Among various classes of metabolic disorders, inborn errors of metabolism are seen as one of a kind of genetic disorders. In this class of metabolic disorders, lack or altered enzyme activity can lead to the disrupted biochemical processes that lead to the pathophysiological conditions (5) (6) (7) (8) (9) (10) (11) (12) (13) . In essence, such metabolic disorders display a condition of either as the aberrant abnormal accumulation of a substrate and on the other hand, a deficit of the product is noticed in a target clinical patient. Further, it is also understood that all such metabolic disorders are inherited in an autosomal recessive manner (5) (6) (7) (8) (9) (10) (11) (12) (13) . Based on literature, more than 500 human diseases depicted as the metabolic disorders are reported in clinical settings. Predominantly, these inborn errors of metabolism are shown to affect more than one children among 1,000 population. Interestingly, in the Indian settings, lack of awareness and established method to adopt genetic and metabolic approaches, these metabolic disorders are remained unnoticed and undetected. Such unnoticed and undetected metabolic disorders from early stage of life to adult stage are documented to be implicated in many human diseases including diabetes and cancer (10) (11) (12) (13) . Hence, metabolic screening is recommended during early stage of life and may also be extended to later part of life.
Among various markers, metabolic acidosis are suggested as one of important display during such metabolic disorders (10) (11) (12) (13) . Currently, various modalities including genetic and metabolomics approaches are reported in literature. However, these methods and processes are faced with limitations in terms of validation accuracy and feasibility of translation at bedside approaches.
In this paper, the authors present an approach that combines the vertical tube gel electrophoresis (VTGE) based fractionation of urine samples and liquid chromatography-high resolution mass spectrometry (LC-HRMS) identification of metabolites in the urine samples of potential human subjects on a pilot experimental basis.
MATERIALS AND METHODS

Collection and preparation of urine samples
Fresh urine samples from healthy clinical subjects were collected in sterile collection tube.
A formal approval was obtained through institutional ethics committee (IEC) and institutional scientific committee (ISC) in accordance with the standard protocol to conduct research on healthy clinical subjects. An informed consent was obtained from the participating healthy clinical subjects. The Further, these urine samples were centrifuged twice at 12000Xg for 30 min. to get rid of debris, dead cells, insoluble particulates and other interfering precipitates. Next, centrifuged urine samples were filtered using 0.45 micron syringe filter to get clear and sterile urine filtrate for subjected to VTGE based fractionation of metabolites.
VTGE based fractionation of metabolites from urine
Sterile filtered urine samples (750 µl) mixed with (250 µl) loading buffer were electrophoresed on VTGE that uses acrylamide gel (acrylamide:bisacrylamide, 30:1) as matrix of 15%. The fractionated elute was collected in electrophoresis running buffer that contains water and glycine and excludes traditional SDS, and other reducing agents. A flow diagram of VTGE method is presented in Figure 1A and 1B that shows the assembly and design of VTGE system (14-15). 
RESULTS
In view of need for the detection of potential metabolites of metabolic disorders, a VTGE method combined with LC-HRMS is used to detect these metabolites as biomarkers in urine samples of healthy clinical subjects. In this paper, VTGE method that employs 15% polyacrylamide gel matrix to fractionate in the range of less than 500 Da. metabolites derived from urine samples. These fractionated urine metabolites were subjected to LC-HRMS to detect the nature of metabolites. Here, electrospray ionization chromatogram (EIC) of 3-methyluridine ( Figure 2 ), 2-methylcitric acid (Figure 3 ) and 2-methyglutaric acid (Figure 4 ) and 2hydroxyglutaric acid ( Figure 5 ). A detailed analysis of molecular structure, mass and polarity of these potential metabolites is given in 
DISCUSSION
In human metabolome database, 2-methylglutaric acid is known as a derivative of leucine metabolite (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . It is suggested that secretion of methylglutaric acid can be found in the urine of patients showing lack of 3-methylglutaconyl coenzyme A hydratase and 3-hydroxy-3methylglutaryl-CoA lyase deficiency during a type of inborn error of metabolisms. Another example of metabolite as 2-Hydroxyglutaric acid is known to be accumulated in an organic aciduria condition (1) (2) (3) (4) (5) . There is an indication that 2-hydroxyglutaric acid can be generated due to the enzymatic action of hydroxyacid-oxoacid transhydrogenase and further 2-Hydroxyglutaric acid is shown to be converted into alpha-ketoglutaric acid by 2-hydroxyglutarate dehydrogenase.
There is a known fact that 2-Hydroxyglutaric acid is produced due to the gain-of-function mutations of isocitrate dehydrogenase enzyme and this enzyme is a part of TCA cycle (1-7).
It is interesting to note that 2-hydroxyglutaric acid may inhibit a range of enzymes such as histone lysine demethylases (KDMs) and members of the ten-eleven translocation (TET) family of 5-methylcytosine (5mC) hydroxylases (1) (2) (3) (4) (5) . In summary, the uses of 2-hydroxyglutaric acid as metabolite biomarkers is having relevance in metabolic disorders and also as a key oncometabolites. In fact, 2-hydroxyglutaric acid is known as an alpha hydroxy acid that belongs to the class of organic compounds as organic acids. There are findings that support that levels of 2-hydroxyglutaric acid are an indicator of inborn error of metabolism as an organic aciduria.
Organic aciduria can be found in both children and adults that shows various symptoms as tremors, sleepiness, headaches, feeling tired, and seizures (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . In line with existing evidence on the potential use of 2-hydroxyglutaric acid, 2-methylglutaric acid, the authors report on a novel methods and processes to detect these urine metabolites as a source of biomarkers for metabolic disorders. 
CONCLUSION
This paper reports on the use of VTGE combined with LC-HRMS technique for the identification of 2-methyluridine, 2-Methylglutaric acid, 2-Methyl citric acid, 2-Hydroxyglutaric acid as potential metabolite biomarkers in case of metabolic disorders clinical subjects. This is report is of novel in the sense that uses new method VTGE to fractionate metabolites from urine samples and further identifications of potential metabolites relevant to metabolic disorders. This study is limited to less number of clinical subjects, however, may be extended to large sample size for application in clinics for the detection of metabolic disorders in children and adult subjects. 
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